alexa Assessing Hepatoxicants based on High-throughput Quantitative SILAC Proteomics and Causal Biological Networks | OMICS International | Abstract
ISSN: 0974-276X

Journal of Proteomics & Bioinformatics
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Assessing Hepatoxicants based on High-throughput Quantitative SILAC Proteomics and Causal Biological Networks

Ahmed Enayetallah1, Sashi Nadanaciva2, Paul Ajuh3, Cristina Vázquez Martín3, Amy Wheat3, Angus Lamond3, Daniel Ziemek4 and Karen L. Leach2,5*

1Translational Medicine, Biogen Idec, Cambridge, Massachusetts, USA

2Compound Safety Prediction, Pfizer Global Research and Development, Pfizer, Inc, Groton, Connecticut, USA

3Dundee Cell Products, Dundee, Scotland

4Computational Sciences Center of Emphasis, Pfizer Global Research and Development, Pfizer, Inc, Berlin, Germany

5Pfizer Global Research and Development, Centers for Therapeutic Innovation, Boston, Massachusetts, USA

*Corresponding Author:
Karen L. Leach
Compound Safety Prediction
Pfizer Global Research and Development
Pfizer, Inc, Groton, Connecticut, USA
Tel: +1 860-441-4100
E-mail: [email protected]

Received date: January 27, 2015; Accepted date: February 17, 2015; Published date: February 25, 2015

Citation: Enayetallah A, Nadanaciva S, Ajuh P, Martín CV, Wheat A, et al. (2015) Assessing Hepatoxicants based on High-throughput Quantitative SILAC Proteomics and Causal Biological Networks. J Proteomics Bioinform 8:049-059. doi:10.4172/jpb.1000352

Copyright: © 2015 Enayetallah A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Drug-induced liver injury can result in the termination of compounds in preclinical development, as well as withdrawal of marketed drugs. Identification of the signaling pathways and proteins involved in injury is an important step towards establishing assays that could be utilized to identify potential hepatotoxicants early in the drug discovery process. In this study we used high throughput quantitative mass spectrometry proteomics involving Stable Isotope Labeling with Amino acids in Cell culture (SILAC) leveraged by a recently developed systems biology approach (Causal Reasoning Engine, CRE) to investigate the effects of hepatotoxic compounds on the cellular proteome of HepG2 cells. Cells were treated with various concentrations of nefazadone, nimesulide, nomifensine, or glafenine, all of which cause hepatotoxicity in humans. Buspirone and rosiglitazone were used as comparator compounds not associated with hepatotoxicity. In comparison to more traditional proteomic analysis tools CRE results provided detailed molecular hypotheses that condense into biological networks and collectively explain a significant number of the measured protein changes. The CRE hypotheses demonstrate that magnitude of response is not necessarily the differentiating factor between DILI and non-DILI compounds but rather the biological processes implicated. Differentiating CRE molecular hypotheses implicate lipid and glucose metabolism, inflammation, oxidative stress and DNA damage as consistent major in vitro discriminating factors. Overall, this paper provides evidence that SILAC data coupled with the CRE analysis method can provide context and new insight into variation of stress responses in hepatotoxic versus non-hepatotoxic compounds even within the same therapeutic class.


Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7